A detailed history of Trail Ridge Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Trail Ridge Investment Advisors, LLC holds 1,865 shares of ABBV stock, worth $363,283. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,865
Previous 1,399 33.31%
Holding current value
$363,283
Previous $254,000 25.59%
% of portfolio
0.17%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $72,132 - $84,234
466 Added 33.31%
1,865 $319,000
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $45,868 - $52,262
-287 Reduced 17.02%
1,399 $254,000
Q4 2023

Feb 16, 2024

SELL
$137.6 - $154.97 $9,632 - $10,847
-70 Reduced 3.99%
1,686 $261,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $234,584 - $271,565
1,756 New
1,756 $261,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $236,726 - $272,625
1,637 New
1,637 $260,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trail Ridge Investment Advisors, LLC Portfolio

Follow Trail Ridge Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trail Ridge Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trail Ridge Investment Advisors, LLC with notifications on news.